Microcurrent device enhances healing rates by up to 50%

New treatments are exciting and Applied Microcurrent Technology’s patented ArcEquine unit, the result of an £850,000 nine-year programme of research and development, both in vitro and in vivo, is being hailed as ‘a phenomenal advance in equine healthcare’. It has gained rapid global credibility with elite international riders and the company has seen growth of over 50% this year alone. The advanced, drug-free and noninvasive microcurrent technology will rapidly reduce all swelling, bruising, inflammation and pain. It will stimulate equally rapid tissue regeneration and repair across a wide spectrum of equine injuries, as evidenced by a growing number of cases...

Interested in the rest of this article?

To access ALL of our amazing content please log in or subscribe.